Timothy J. Schroeder, Director at Inmune Bio, Inc. (INMB), sold 10,000 shares at $11.01 ($110K) on 2023-07-12, disclosed to the SEC on 2023-07-14.
Scheduled sale ($110k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| INMB | SELL | 2021-06-15 | $190K | — | Filing → |
| INMB | SELL | 2021-06-14 | $340K | — | Filing → |
| INMB | SELL | 2021-04-01 | $120K | — | Filing → |